📰 Simulations Plus News
Page 11 - Simulations Plus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simulations Plus. Real-time updates on events, politics, business and more.
May 10, 2023
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (HCAT – Research Report), ForgeRock Inc (FORG...
May 10, 2023
Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated pulmonary software... | May 10, 2023
May 10, 2023
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated pulmonary software and services package. This targeted package will support pharmaceuti...
May 9, 2023
The Wall Street firm said this stock is a category leader for model-informed drug development (MIDD), or simulations for biotech drug trials.
April 27, 2023
Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, April 26th. The stock was sold at an average price of $41.52, for a total transaction of $830,400.00. Following the completion of the transaction, the director now directly owns 3,875,739 shares in […]
April 18, 2023
Provides FDA with software tools to investigate drug-induced liver injury in clinical trials ... | April 18, 2023
April 13, 2023
/PRNewswire/ -- The global Bio Simulation Market is projected to grow at a CAGR of 16.20% from 2023 to 2030, according to a new report published by Verified...
April 11, 2023
Computational drug design and cloud computing may increase success rates for drug candidates and decrease processing costs.
April 8, 2023
Operator: Greetings, and welcome to the Simulations Plus Second Quarter Fiscal 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
April 8, 2023
Simulations Plus (NASDAQ:SLP – Get Rating) issued an update on its FY 2023 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.63-$0.67 for the period, compared to the consensus estimate of $0.65. The company issued revenue guidance of $59.30 million-$62.00 million, compared to the consensus revenue estimate of $60.79 […]